Skip to content

A randomized controlled trial of efficacy and safety of salpingotomy transvaginal natural orifice transluminal endoscopic surgery(V-Notes) with anterior and posterior fornix approaches

A randomized controlled trial of efficacy and safety of salpingotomy transvaginal natural orifice transluminal endoscopic surgery(V-Notes) with anterior and posterior fornix approaches

Status
Active, not recruiting
Phases
Early Phase 1
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2000037482
Enrollment
Unknown
Registered
2020-08-28
Start date
2020-09-01
Completion date
Unknown
Last updated
2020-10-19

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

diseases of gynecology

Interventions

1:Salpingectomy was performed by transvaginal anterior vaginal fornix approach
2:Salpingectomy was performed by transvaginal posterior vaginal fornix approach

Sponsors

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China
Lead Sponsor

Eligibility

Sex/Gender
Female

Inclusion criteria

Inclusion criteria: (1) Aged >=18 years old; (2) Patients with tubal pregnancy require salpingectomy on the affected side, and laparoscopic surgery (non-emergency surgery) is proposed; (3) The vital signs are stable and can tolerate laparoscopic surgery; (4) In the absence of severe pelvic cavity tuberculosis or severe pelvic inflammatory sequelae, the gynecological examination showed good uterine activity; (5) The patient understands the research plan and is willing to participate in the research, and provides written informed consent.

Exclusion criteria

Exclusion criteria: (1) Emergency tubal pregnancy surgery; (2) Acute infection, preoperative deep vein thrombosis or hypercoagulability, fasting blood glucose>11.1 mmol/L, blood pressure >160/100mmhg, liver and kidney dysfunction, mental illness and other surgical contraindications; (3) Bladder/rectal surgery history; (4) Suspected anteroposterior concave adhesion or rectovaginal septal endometriosis or tumor; (4) Asexual life or pregnancy; (5) Previous history of pelvic tuberculosis or severe pelvic inflammatory disease sequelae;

Design outcomes

Primary

MeasureTime frame
The time between the beginning of the operation and its entry into the abdominal cavity;Whether there is bladder damage or rectal damage;time of operation;intraoperative blood loss;Whether there is a transition to umbilical laparoscopic surgery;

Secondary

MeasureTime frame
Postoperative anal exhaust time;Postoperative Visual Analogue Scale score;Post Operative Nausea And Vomitting;Body Image Scale/Cosmetic Scale;Patient Satisfaction;average length of stay;

Countries

China

Contacts

Public ContactYonghong Lin

Chengdu Women's and Children's Central Hospital, School of Medicine, University of Electronic Science and Technology of China

linyh.2007@aliyun.com+86 13808031895

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026